Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma

Journal of Cutaneous Pathology

Volumn 41, Issue 11, 2014, Pages 846-852

  Henderson, Samuel A ^a   Tetzlaff, Michael T ^a   Pattanaprichakul, Penvadee ^a,b   Fox, Patricia ^a   Torres Cabala, Carlos A ^a   Bassett, Roland L ^a   Prieto, Victor G ^a   Richards, Hunter W ^c   Curry, Jonathan L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

biomarker; H3K79me3T80ph; histones; Merkel cell carcinoma; PHH3

Indexed keywords

HISTONE; TUMOR MARKER;

AGED; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MERKEL CELL TUMOR; MIDDLE AGED; MITOSIS; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SKIN TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, MERKEL CELL; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS;

EID: 84913553400     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12383     Document Type: Article

References (35)

1. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH,. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37 (5 Pt 1): 734.
2. Coit DG,. Merkel cell carcinoma. Ann Surg Oncol 2001; 8 (9 Suppl): 99S.
3. Brown JA, Smoller BR,. Merkel cell carcinoma: what is it, what will it do and where will it go? What role should the pathologist play in reporting this information? J Cutan Pathol 2009; 36: 924.
4. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751.
5. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096.
6. Mott RT, Smoller BR, Morgan MB,. Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol 2004; 31: 217.
7. Koljonen V, Bohling T, Granhroth G, Tukiainen E,. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003; 29: 607.
8. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG,. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23: 2300.
9. Schwartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011; 29: 1036.
10. Tarantola TI, Vallow LA, Halyard MY, et al. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol 2013; 68: 425.
11. Asioli S, Righi A, Volante M, Eusebi V, Bussolati G,. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007; 110: 640.
12. Kim J, McNiff JM,. Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod Pathol 2008; 21: 764.
13. Tetzlaff MT, Curry JL, Ivan D, et al. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 2013; 26: 1153.
14. Martinez DR, Richards HW, Lin Q, et al. H3K79me3T80ph is a novel histone dual modification and a mitotic indicator in melanoma. J Skin Cancer 2012; 2012: 823534.
15. Nowak M, Svensson MA, Carlsson J, et al. Prognostic significance of phospho-histone H3 in prostate carcinoma. World J Urol 2014; 32: 703.
16. Colman H, Giannini C, Huang L, et al. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 2006; 30: 657.
17. Rao P, Balzer BL, Lemos BD, et al. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med 2010; 134: 341.
18. Rose CL, Chakravarti N, Curry JL, et al. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol 2012; 39: 762.
19. Andea AA, Coit DG, Amin B, Busam KJ,. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113: 2549.
20. Fields RC, Busam KJ, Chou JF, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011; 254: 465 discussion 473.
21. Hall BJ, Pincus LB, Yu SS, Oh DH, Wilson AR, McCalmont TH,. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol 2012; 39: 911.
22. Asioli S, Righi A, de Biase D, et al. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Mod Pathol 2011; 24: 1451.
23. Stetsenko GY, Malekirad J, Paulson KG, et al. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Am J Clin Pathol 2013; 140: 838.
24. Fleming KE, Ly TY, Pasternak S, Godlewski M, Doucette S, Walsh NM,. Support for p63 expression as an adverse prognostic marker in Merkel cell carcinoma: report on a Canadian cohort. Hum Pathol 2014; 45: 952.
25. Dabner M, McClure RJ, Harvey NT, et al. Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome. Pathology 2014; 46: 205.
26. Higaki-Mori H, Kuwamoto S, Iwasaki T, et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 2012; 43: 2282.
27. Fernandez-Figueras MT, Puig L, Musulen E, et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol 2007; 20: 90.
28. Vlahova L, Doerflinger Y, Houben R, et al. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival. Br J Dermatol 2012; 166: 1043.
29. Koljonen V, Tukiainen E, Haglund C, Bohling T,. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology 2006; 49: 551.
30. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005; 46: 622.
31. Vujic I, Marker M, Posch C, et al. Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression. J Eur Acad Dermatol Venereol 2014; [Epub ahead of print; DOI: 10.1111/jdv.12626 ].
32. Hammond SL, Byrum SD, Namjoshi S, et al. Mitotic phosphorylation of histone H3 threonine 80. Cell Cycle 2014; 13: 440.
33. Bossard C, Jarry A, Colombeix C, et al. Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol 2006; 59: 706.
34. Gudlaugsson E, Skaland I, Janssen EA, et al. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology 2012; 61: 1134.
35. Draganova-Tacheva R, Bibbo M, Birbe R, Daskalakis C, Solomides C,. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens. Acta Cytol 2013; 57: 291.